Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

35.95
Delayed Data
As of Aug 28
 -0.17 / -0.47%
Today’s Change
33.75
Today|||52-Week Range
45.43
-3.93%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 44.00, with a high estimate of 53.00 and a low estimate of 34.00. The median estimate represents a +22.39% increase from the last price of 35.95.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Hold stock in Haemonetics Corp. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.39
Sales
$226.7M
Reporting Date
Nov 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.00%
 
 
 
 
 
 
Growthannually 9.24%
 
 
 
 
 
 

Sales

Growthquarterly 6.23%
 
 
 
 
 
 
Growthannually 3.99%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.